BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27430400)

  • 1. Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary study.
    Peacock A; Bruno R; Larance B; Lintzeris N; Nielsen S; Ali R; Dobbins T; Degenhardt L
    Drug Alcohol Depend; 2016 Sep; 166():125-33. PubMed ID: 27430400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
    Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.
    Peacock A; Degenhardt L; Larance B; Cama E; Lintzeris N; Ali R; Bruno R
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1321-33. PubMed ID: 26419615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics of a cohort who tamper with prescribed and diverted opioid medications.
    Larance B; Lintzeris N; Bruno R; Peacock A; Cama E; Ali R; Kihas I; Hordern A; White N; Degenhardt L
    J Subst Abuse Treat; 2015 Nov; 58():51-61. PubMed ID: 26286818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014.
    Calcaterra SL; Severtson SG; Bau GE; Margolin ZR; Bucher-Bartelson B; Green JL; Dart RC
    Clin Toxicol (Phila); 2018 Nov; 56(11):1107-1114. PubMed ID: 29609498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.
    Mateu-Gelabert P; Jessell L; Goodbody E; Kim D; Gile K; Teubl J; Syckes C; Ruggles K; Lazar J; Friedman S; Guarino H
    Int J Drug Policy; 2017 Aug; 46():17-27. PubMed ID: 28577506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality.
    Dasgupta N; Funk MJ; Proescholdbell S; Hirsch A; Ribisl KM; Marshall S
    Pain Med; 2016 Jan; 17(1):85-98. PubMed ID: 26333030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study.
    Larance B; Dobbins T; Peacock A; Ali R; Bruno R; Lintzeris N; Farrell M; Degenhardt L
    Lancet Psychiatry; 2018 Feb; 5(2):155-166. PubMed ID: 29336948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
    Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
    Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017.
    Tori ME; Larochelle MR; Naimi TS
    JAMA Netw Open; 2020 Apr; 3(4):e202361. PubMed ID: 32271389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population.
    Hung A; Bush C; Greiner M; Campbell H; Hammill B; Maciejewski ML; McKethan A
    J Manag Care Spec Pharm; 2020 Feb; 26(2):169-175. PubMed ID: 32011957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study.
    Sharma V; Weir D; Samanani S; Simpson SH; Gilani F; Jess E; Eurich DT
    BMJ Open; 2019 Sep; 9(9):e030858. PubMed ID: 31494618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid and benzodiazepine misuse in the United States: The impact of socio-demographic characteristics.
    Haider MR; Jayawardhana J
    Am J Addict; 2024 Jan; 33(1):71-82. PubMed ID: 37689992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later--a follow-up study of 13,390 men and women aged 40-42 years.
    Skurtveit S; Furu K; Bramness JG; Tverdal A
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):926-933. PubMed ID: 18489010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.
    Schuman-Olivier Z; Hoeppner BB; Weiss RD; Borodovsky J; Shaffer HJ; Albanese MJ
    Drug Alcohol Depend; 2013 Oct; 132(3):580-6. PubMed ID: 23688843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort.
    Campbell G; Nielsen S; Larance B; Bruno R; Mattick R; Hall W; Lintzeris N; Cohen M; Smith K; Degenhardt L
    Pain Med; 2015 Sep; 16(9):1745-58. PubMed ID: 26011277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010.
    Jones CM; Paulozzi LJ; Mack KA;
    MMWR Morb Mortal Wkly Rep; 2014 Oct; 63(40):881-5. PubMed ID: 25299603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.